May 16, 2019
Pharming Group net profit up for Q1 2019
Revenues increased approximately 19.5% to €35.2 million, compared with €29.5 million during the same period last year.
Pharmaceuticals, Biotechnology and Life Sciences
Revenues increased approximately 19.5% to €35.2 million, compared with €29.5 million during the same period last year.
Dutch Pharming Group N.V. was profitable at the net level in every quarter and for the year as a whole, with the total net profit for the year ended at €25.0 million, representing a net margin of 19% and well ahead of analysts’ forecasts.